Home/Filings/4/0001562180-21-004607
4//SEC Filing

Glanzman Robert 4

Accession 0001562180-21-004607

CIK 0001822791other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 9:20 AM ET

Size

4.9 KB

Accession

0001562180-21-004607

Insider Transaction Report

Form 4
Period: 2021-06-30
Glanzman Robert
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-06-30+15,28115,281 total
Footnotes (1)
  • [F1]This restricted stock award was granted on June 30, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on January 15, 2022.

Issuer

Clene Inc.

CIK 0001822791

Entity typeother

Related Parties

1
  • filerCIK 0001835428

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 9:20 AM ET
Size
4.9 KB